Beranda › Kanker Kepala dan Leher › Missouri
Uji klinis Kanker Kepala dan Leher di Missouri
16 studi untuk Kanker Kepala dan Leher mencari peserta di lokasi di Missouri.
Kota di Missouri
Teks studi resmi (Bahasa Inggris)
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
- Site #0114, St Louis
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06788990A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Washington University, School of Medicine, St Louis
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06172478Online Perioperative Education Program on Patient Satisfaction and Clinical Outcomes for Head and Neck Surgery
- Washington University School of Medicine, St Louis
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07848841First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
- Washington University, St Louis
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT06657222Building a Renewed ImaGe After Head & Neck Cancer Treatment (BRIGHT) Multi-Site RCT
- Washington University in St. Louis, St Louis
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT05442957Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
- Washington University School of Medicine, St Louis
Menerima pesertaStudi observasional
Usia 18 hingga 50 · Wanita · Diperbarui 2 Sep 2026 · NCT06904365IDOV-Immune for Advanced Solid Tumors
- Washington University School of Medicine, St Louis
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Agu 2026 · NCT06910657First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- Saint Luke's Cancer Institute, Kansas City
- Washington University, St Louis
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Jul 2026 · NCT05768139Lead-212 PSV359 Therapy for Patients With Solid Tumors
- Saint Louis University, St Louis
Menerima pesertaFase 1/2
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT06710756Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
- Mercy Hospital - SPG, Springfield
- Mercy Hospital - South, St Louis
- Mercy Hospital -STL, St Louis
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT07327489A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Washington University Infusion Center Pharmacy, St Louis
Menerima pesertaFase 1/2
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 27 Mei 2026 · NCT03093116A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
- GSK Investigational Site, St Louis
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 26 Mei 2026 · NCT06256588Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
- Washington University School of Medicine, St Louis
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Feb 2026 · NCT04354064Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy
- Washington University in St. Louis, St Louis
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Des 2025 · NCT05793151SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Kansas City
- Massive Bio SYNERGY-AI site, St Louis
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 28 Okt 2025 · NCT03452774Testing Less Intensive Radiation With Chemotherapy to Treat Low-risk Patients With HPV-positive Oropharyngeal Cancer
- University of Missouri, Columbia
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Mei 2024 · NCT04444869Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.